UCLA's Bladder Cancer Program is a multidisciplinary comprehensive program offering the latest treatments for bladder cancer and compassionate care, and is affiliated with the Institute of Urologic Oncology and the Jonsson Comprehensive Cancer Center. UCLA has a long-held team approach to treating bladder cancer that includes urologists, medical oncologists, radiation oncologists, pathologists, radiologists and clinical trial nurses that allows for specialized perspectives for deciding upon the best option for each individual patient.
UCLA urologist, Karim Chamie, MD, MSHS, presented a live-streaming webinar to discuss new cancer treatments that do not require the unnecessary removal of the kidney or bladder.
What is Bladder Cancer?
Bladder cancer is marked by the formation of malignant cells in the tissues of the bladder, the organ where urine is stored. The bladder is an organ located in the lower abdomen used to store urine.
The urine travels from the kidneys to the bladder by two paired tubes called ureters. Bladder cancer occurs when uncontrolled growth and malignancy develops from cells originating from the bladder lining or urothelium. Bladder cancer is the fourth most common cancer in men and the eighth most common cancer in women. According to the American Cancer Society’s 2013 statistics, more than 72,000 new cases of bladder cancer are diagnosed in the United States each year, and the current annual death toll is expected to exceed 15,000.
Learn more about Types of Bladder Cancer, Incidence Rate and Risk Factors >
For an appointment with a UCLA bladder cancer specialist, call (310) 794-7700.
Real Questions/Real Answers Video
Meet Our Doctors >
The Department of Urology at UCLA is one of the most progressive and comprehensive urology programs in the country. Our faculty members work side by side with research scientists for new cures and treatments for bladder cancer.